Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Determine the Effect of QVA149 on Mean 24-hours Heart Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00558285 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00558285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00558285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Determine the Effect of QVA149 on Mean 24-hours Heart Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
July 31, 2008
Enrollment
257 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)